Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation for Anal Carcinoma
NCT00316888Phase 2Completed
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Feb 2007
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in anal cancer, sponsored by ECOG-ACRIN Cancer Research Group. Started Feb 2007; status: completed.
02
Drugs
KL-140
03
Conditions
anal cancer
Beyond the preview
Go deeper on NCT00316888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316888.